Home › Funds › BVF INC/IL › FHTX

BVF INC/IL position in FHTX

FOGHORN THERAPEUTICS INC · Health Care

BVF INC/IL reported holding 5,842,000 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$28.5M, representing 0.73% of its reported portfolio and ranking #29 among its reported holdings. BVF INC/IL has disclosed FHTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)5.84M sh
Reported value held$28.51M
Portfolio Weight0.73%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's FHTX position evolved

BVF INC/IL first disclosed a stake in FHTX in Q2 2024 at 5,302,000 shares (US$30.5M). The position peaked in Q3 2024 at 5,302,000 shares, worth US$49.4M. Across 9 filings, BVF INC/IL increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 5,842,000 shares valued at US$28.5M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 5.30M $30.49M New
Q3 2024 5.30M $49.36M Hold
Q4 2024 5.30M $25.03M Hold
Q1 2025 5.30M $19.35M Hold
Q2 2025 5.30M $24.92M Hold
Q3 2025 5.30M $25.93M Hold
Q4 2025 5.30M $28.63M Hold
Q1 2026 5.84M $27.92M Add
Q2 2026 5.84M $28.51M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FHTX and 13F data

FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in FHTX — the largest reported positions include Flagship Pioneering, LLC (US$61.8M), Euclidean Capital LLC (US$7.7M), Birchview Capital, LP (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FHTX

All FHTX fund holders →

FAQ

How long has BVF INC/IL held FHTX?

BVF INC/IL has disclosed FHTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is BVF INC/IL's current position in FHTX?

As of Q2 2026, BVF INC/IL holds 5.84M shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $28.51M, representing 0.73% of its reported portfolio and ranking #29.

Has BVF INC/IL been buying or selling FHTX?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in FHTX. The position peaked in Q3 2024 at 5.30M shares.

Which other funds hold FHTX?

Other major institutional holders of FHTX include Flagship Pioneering, LLC, Euclidean Capital LLC, Birchview Capital, LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.